FLK-43905-84391
4 vaccinations
7 coded responses
40 check-ins
6 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 633 / MO
- Registered
- 2020-12-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-28
Registered in v-safe
-
2020-12-28
Dose 1 — Pfizer-BioNTech
- 2020-12-28
- 2020-12-29
- 2020-12-30
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-13
-
2021-01-15
Dose 2 — Pfizer-BioNTech
- 2021-02-21
- 2021-02-26
- 2021-04-16
- 2021-07-16
-
2021-09-27
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-09-29
- 2021-09-30
- 2021-10-01
-
2021-10-02
Survey response — days 1–6 daily, dose 3MedDRA: Back pain — Feeling: FairFree text: Unrelated back painMedDRA releases: 2024-11 · check-in free text available
- 2021-10-04
- 2021-10-11
- 2021-10-19
- 2021-10-25
- 2021-11-01
- 2021-11-08
- 2021-12-27
-
2022-03-28
Survey response — 6 months, dose 3MedDRA: Cough, Fatigue, Headache, Office visit, Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test negative, Upper respiratory tract infection — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Upper respiratory infection, runny nose, congested, coarse cough, fatigue, headache X 8 days. Covid negative x 2, days 3 & 8. Seen by PMD, started on 10 day coarse of augmentin. Improvment within 24 hours, resolved day 12. · Healthcare visit (other): Primary care, nurse practionerMedDRA releases: 2024-11 · check-in free text available
-
2022-03-28
Report sent to call center — 6 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2022-03-30
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-04-20
Dose 4 — Pfizer-BioNTech
-
2022-04-21
Survey response — days 1–6 daily, dose 4MedDRA: Cough — Feeling: GoodFree text: CoughMedDRA releases: 2024-11 · check-in free text available
-
2022-04-22
Survey response — days 1–6 daily, dose 4MedDRA: Emergency care, Tachycardia — Feeling: Fair · Muscle or body aches, Fatigue or tiredness · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: In the ER now for evaluation of persistent tachycardiaMedDRA releases: 2024-11 · check-in free text available
-
2022-04-22
Report sent to call center — days 1–6 daily, dose 4Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
-
2022-04-23
Survey response — days 1–6 daily, dose 4MedDRA: Emergency care, Laryngitis, Pneumonia, Tachycardia — Feeling: Fair · Fatigue or tiredness · Be unable to work or attend schoolFree text: Diagnosed with LUL pneumonia, got dose of Rocephin in ED and now on a z-pac. Also have laryngitis , tachycardia improved.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-24
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
- 2022-04-25
- 2022-04-26
- 2022-04-26
-
2022-04-26
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-04-27
- 2022-05-04
- 2022-05-11
- 2022-05-18
- 2022-05-25
- 2022-06-01
-
2022-07-20
Survey response — 3 months, dose 4MedDRA: COVID-19, Diarrhoea, Dysphonia, Emergency care, Fatigue, Gastrointestinal disorder, Headache, Nausea, Rhinorrhoea, Supraventricular tachycardia, Urinary tract infection, Vomiting — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Bad. GI virus with vomiting , diarrhea, and fatigue, week later with a positive Covid , symptoms mild, mainly headache, runny nose , hoarseness, and fatigue.ER visit for SVT. Week after that developed a urinary tract infection requiring antibioticsMedDRA releases: 2024-11 · check-in free text available
-
2022-07-20
Report sent to call center — 3 months, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
-
2022-07-21
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-10-19
-
2023-04-20
Survey response — 12 months, dose 4MedDRA: Cough, Increased upper airway secretion — Feeling: GoodMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-28 | Pfizer-BioNTech | |
| 2 | 2021-01-15 | Pfizer-BioNTech | |
| 3 | 2021-09-27 | Pfizer-BioNTech | Flu |
| 4 | 2022-04-20 | Pfizer-BioNTech | No |
Call center
3 call center cases
3 successful
Free text
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Unrelated back pain
Release 11 — 6 months, dose 3
Symptoms: Upper respiratory infection, runny nose, congested, coarse cough, fatigue, headache X 8 days. Covid negative x 2, days 3 & 8. Seen by PMD, started on 10 day coarse of augmentin. Improvment within 24 hours, resolved day 12.
Healthcare visit (other): Primary care, nurse practioner
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): Cough
Systemic reaction (other): In the ER now for evaluation of persistent tachycardia
Systemic reaction (other): Diagnosed with LUL pneumonia, got dose of Rocephin in ED and now on a z-pac. Also have laryngitis , tachycardia improved.
Release 12 — 3 months, dose 4
Symptoms: Bad. GI virus with vomiting , diarrhea, and fatigue, week later with a positive Covid , symptoms mild, mainly headache, runny nose , hoarseness, and fatigue.ER visit for SVT. Week after that developed a urinary tract infection requiring antibiotics cut off by CDC
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Dysphonia | · | · | ✓ |
| SD | Emergency care | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Gastrointestinal disorder | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Increased upper airway secretion | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Office visit | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Supraventricular tachycardia | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SD | Urinary tract infection | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
| SRO | Back pain | · | · | ✓ |
| SRO | Cough | · | · | ✓ |
| SRO | Emergency care | · | · | ✓ |
| SRO | Laryngitis | · | · | ✓ |
| SRO | Pneumonia | · | · | ✓ |
| SRO | Tachycardia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release